8-K 1 a5460823.txt POLYMEDICA CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2007 POLYMEDICA CORPORATION (Exact Name of Registrant as Specified in Charter) Massachusetts 0-19842 04-3033368 -------------------------------------------------------------------------------- (State or Other Jurisdiction of (Commission (IRS Employer Incorporation File Number) Identification No.) 701 Edgewater Drive, Suite 360 Wakefield, Massachusetts 01880 -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (781) 486-8111 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) -------------------------------------------------------------------------------- TABLE OF CONTENTS ----------------- Item 2.02. Results of Operations and Financial Condition Item 9.01. Financial Statements and Exhibits SIGNATURE EXHIBIT INDEX Ex-99.1 Press Release, dated July 31, 2007, of PolyMedica Corporation -------------------------------------------------------------------------------- Item 2.02. Results of Operations and Financial Condition On July 31, 2007, PolyMedica Corporation (the "Company") announced the financial results of its fiscal 2008 first quarter ended June 30, 2007. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K. On August 1, 2007, at 9:00 AM Eastern, the Company intends to hold a conference call and webcast to discuss the financial results reported in the press release. Instructions on accessing the conference call are included in the press release. The information in this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description -------------- ----------- 99.1 Press Release, dated July 31, 2007, of PolyMedica Corporation -------------------------------------------------------------------------------- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. POLYMEDICA CORPORATION Date: July 31, 2007 By: /s/ Devin J. Anderson -------------------------------------------- Devin J. Anderson General Counsel and Secretary -------------------------------------------------------------------------------- EXHIBIT INDEX Exhibit Number Description -------------- ----------- 99.1 Press Release, dated July 31, 2007, of PolyMedica Corporation